BackgroundCardiovascular 疾病和维生素 D 的不够的层次是为不利外科的结果的风险因素，并且他们是在经历整形外科的外科的更老的成年人之中通常在场的两个。给维生素 D 的心血管的效果， hypovitaminosis D 的外科手术前的诊断将是为...BackgroundCardiovascular 疾病和维生素 D 的不够的层次是为不利外科的结果的风险因素，并且他们是在经历整形外科的外科的更老的成年人之中通常在场的两个。给维生素 D 的心血管的效果， hypovitaminosis D 的外科手术前的诊断将是为补充协议的实现的珍贵的步。如果，我们调查了浆液 25 的正规化[哦] D 能改善受不了心血管的 diseases.MethodsWe 的更老的成年人的心脏的性能注册了为主要整形外科的外科安排的 47 个更老的成年人并且受不了 hypovitaminosis D。病人们与开始的剂量经历了 6 月的 calcifediol 补充 50 湩琠敨攠敶瑮的起初手术后的白天吗？展开更多
Systemic autoimmune diseases are characterized by an excess of cardiovascular(CV) morbidity and mortality compared to the general population,mainly due to chronic inflammation that promotes the development of endothel...Systemic autoimmune diseases are characterized by an excess of cardiovascular(CV) morbidity and mortality compared to the general population,mainly due to chronic inflammation that promotes the development of endothelial dysfunction and enhanced atherosclerosis.Early diagnosis of silent CV involvement is mandatory to improve the long term prognosis of these patients and CV imaging provides valuable information as a reliable diagnostic tool.Transthoracic echocardiography,with several applications(e.g.coronary flow reserve evaluation,tissue Doppler imaging,speckle tracking and the transesophageal approach),represents a first line evaluation,in association with biomarkers of endothelial dysfunction,such as asymmetric dimethylarginine.Nuclear medicine provides useful information on myocardial perfusion.The aim of this editorial is to provide a brief but complete review of the diagnostic tools available for screening and follow up of CV involvement in systemic autoimmune diseases.展开更多
文摘Systemic autoimmune diseases are characterized by an excess of cardiovascular(CV) morbidity and mortality compared to the general population,mainly due to chronic inflammation that promotes the development of endothelial dysfunction and enhanced atherosclerosis.Early diagnosis of silent CV involvement is mandatory to improve the long term prognosis of these patients and CV imaging provides valuable information as a reliable diagnostic tool.Transthoracic echocardiography,with several applications(e.g.coronary flow reserve evaluation,tissue Doppler imaging,speckle tracking and the transesophageal approach),represents a first line evaluation,in association with biomarkers of endothelial dysfunction,such as asymmetric dimethylarginine.Nuclear medicine provides useful information on myocardial perfusion.The aim of this editorial is to provide a brief but complete review of the diagnostic tools available for screening and follow up of CV involvement in systemic autoimmune diseases.
